Início › Melanoma › Nova York

Ensaios clínicos de Melanoma em Nova York

50 estudos para Melanoma estão buscando participantes em locais em Nova York.

Cidades em Nova York

Texto oficial do estudo (Inglês)

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

START New York Long Island LLC, Lake Success

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06270706

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Roswell Park Cancer Institute IDS, Buffalo
Memorial Sloan Kettering Hospital, New York

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06172478

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

NYU Langone Hospital - Long Island, Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05136196

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

New York Oncology Hematology, Albany

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06246916

Pan-tumor MRD Study

Guthrie Lourdes Memorial Hospital (GLMH), Binghamton
New York Cancer & Blood Specialists, Shirley

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06605404

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Roswell Park Cancer Institute, Buffalo
Glens Falls Hospital, Glens Falls
NYU Langone Hospital - Long Island, Mineola
e mais 4

RecrutandoFase 3

Idades 75 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT07068074

Intratumoral N17350 in Advanced Solid Tumors

Roswell Park Comprehensive Cancer Center, Buffalo

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07339176

Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade

Weill Cornell Medicine, New York

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07661966

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT04752826

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Local Institution - 0142, Buffalo
Local Institution - 0170, New York
Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07492680

A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma

Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT05607095

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

START Cancer Research New York-Long Island, Lake Success

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT07287917

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients

Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06284590

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
e mais 1

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT05837767

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

NYU Langone, New York

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT04913285

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Memorial Sloan Kettering Hospital, New York

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT07070232

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

NYU Langone Hospital - Long Island, Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 31 de ago. de 2026 · NCT05896839

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

RecrutandoFase 1/2

12 Months – 30 Years · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT04851119

Project: Every Child for Younger Patients With Cancer

Albany Medical Center, Albany
Maimonides Medical Center, Brooklyn
Roswell Park Cancer Institute, Buffalo
e mais 12

RecrutandoEstudo observacional

Até 25 anos · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT02402244

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

NYU Langone Health, New York

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT07504796

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

Weill Cornell Medicine - New York Presbyterian Hospital, New York

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 14 de ago. de 2026 · NCT06425926

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 12 de ago. de 2026 · NCT05859074

A Study of MGC026 in Participants With Advanced Solid Tumors

START-New York Long Island, Lake Success

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT06242470

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

NYU Langone Health, New York
Icahn School of Medicine At Mount Sinai Prime, New York
Clinical Research Alliance, Inc, Westbury
e mais 1

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT06330064

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Roswell Park Cancer Institute, Buffalo

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 28 de jul. de 2026 · NCT06150664

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Memorial Sloan Kettering (Melanoma/NSCLC), New York

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT06060613

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Call for Information (Investigational Site 0031), New York

RecrutandoFase 1/2

6 Months – 17 Years · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT02332668

Integrated Cancer Repository for Cancer Research

C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
Faxton St. Luke's Healthcare, Mohawk Valley, Utica

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 19 a 110 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT02012699

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Weill Medical College of Cornell University, New York
Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 1/2

Idades de 18 a 70 · Todos os sexos · Atualizado em 11 de jun. de 2026 · NCT05361174

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

USA04-0, New York

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de mai. de 2026 · NCT06953089

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Perlmutter Cancer Center at NYU Langone Health, New York
Memorial Sloan-Kettering Cancer Center, New York
Columbia University, New York

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 15 de mai. de 2026 · NCT05379985

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 13 de mai. de 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Herbert Irving Comprehensive Cancer Center, New York
Memorial Sloan Kettering Cancer Center - 1275 York Ave, New York
Northwell Health Cancer Institute, New York

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 6 de mai. de 2026 · NCT07015190

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Northwell Health, Lake Success

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 28 de abr. de 2026 · NCT06413680

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

Roswell Park, Buffalo
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
Columbia University Medical Center, New York
e mais 1

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 20 de abr. de 2026 · NCT06326411

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 2/3

Todas as idades · Todos os sexos · Atualizado em 2 de abr. de 2026 · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Glens Falls Hospital, Glens Falls
Queens Hospital Center, Jamaica
Montefiore Medical Center-Einstein Campus, The Bronx
e mais 1

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 17 de mar. de 2026 · NCT06418204

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Northwell Health Cancer Institute - Zuckerberg Cancer Center, Lake Success
Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de fev. de 2026 · NCT05549297

ACTengine® IMA203 Combined With mRNA-4203

Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 8 de jan. de 2026 · NCT06946225

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.